Platinum based cancer drugs, also known as platinating agents, are a type of chemotherapy drug that use platinum to treat cancer. These drugs work by binding to DNA strands in the cancer cells and causing them to break down and die. Some of the most commonly used platinum based drugs for cancer treatment are cisplatin, carboplatin, and oxaliplatin. These drugs have been used in the treatment of a variety of cancer types, including lung, ovarian, bladder, prostate, colorectal, and testicular cancers.
Platinum based drug’s usage has increased over the past several decades as new and more effective cancer treatments have become available. The main drivers of this growth are increasing prevalence of cancer in aging populations and the availability of new and more effective platinum based drugs.
The global Platinum based Cancer Drug market was valued at US$ 1541.9 million in 2022 and is anticipated to reach US$ 1862.2 million by 2029, witnessing a CAGR of 2.7% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
A detailed market research report on Global Platinum based Cancer Drug Market available at: https://www.themarketreports.com/report/global-platinum-based-cancer-drug-market-research-report
This report aims to provide a comprehensive presentation of the global market for Platinum based Cancer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum based Cancer Drug.
Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.
Ask for more details or sample of this report at: https://www.themarketreports.com/report/ask-your-query/1409644
Release by:
Shirish Gupta
Marketing Manager
The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email:sales@themarketreports.com